Preimplantation Genetics Diagnosis Trends and Forecast
The future of the global preimplantation genetics diagnosis market looks promising with opportunities in the diagnostic laboratory, hospital, and clinic markets. The global preimplantation genetics diagnosis market is expected to reach an estimated $0.20 billion by 2030 with a CAGR of 10.7% from 2024 to 2030. The major drivers for this market are rising prevalence of genetic disorder, growing awareness about the role of genetics in reproductive health, and technological advancement in the fertility treatments.
Country Wise Outlook for the Preimplantation Genetics Diagnosis Market
The pre-implantation genetic diagnosis (PGD) market is changing swiftly due to the improvements in reproductive techniques, the growing knowledge regarding genetic diseases, and the increasing focus on individualized medicine. In this manner, PGD is becoming more innovative and available, allowing couples at risk to make wiser reproductive decisions. The market structure operates differently in different countries within the world, where regions like the US, China, Germany, India, and Japan are at a cut above in terms of the technology and regulatory policies. Each of the regions is experiencing some developments that are different and which contribute towards efficiency and wider acceptance of PGD.
• United States: Turning to the U.S. market, competition in the PGD segment has spurred on technology advancements including next-generation sequencing which improves the precision of tests. As a result, clinics have incorporated microarray based pre-implantation genetic diagnosis and prophylactic in vitro fertilization. The regulation of genetic testing services by the Federal drug authorities has also compelled these service providers to improve on market chains. More importantly, the widespread availability of telemedicine is opening up for PGD consultations for couples throughout the country. Growing genetic literacy and tolerance towards tests seem to increase the need for PGD services.
• China: The PGD market has been growing rapidly in China due to the increasing recognition of genetic disorders and the development of reproductive technology. The government supports health programs that include genetic screening as a factor in family planning programs. Chinese facilities are now employing new but advanced techniques like NGS, which increases the precision in PGD application. Nevertheless, the issues related to genetic alteration and governing the provision of genetic tests are still problematic. More and more people are demanding PGD as they wish to have healthy children free from genetic diseases.
• Germany: GermanyÄX%$%Xs PGD market has a high degree of establishment that mediates each PGD service with legal and ethical procedures. In the country, the PGD is practically prohibited in its use, hence the need for such technology is confined mostly to few cases of highly genetic diseases. On the other hand, technological growth within the field of genetics like cellular eating moving forward to single cell sequencing constitutes great developments towards PGD and its applications in the future. The clinical laboratories are working with other research bodies to come up with new workable prototypes of genetic screening techniques. Given the rising population interest in genetic health, there is growing speculation on the policy reforms that would enable wider access to PGD services.
• India’s: PGD market is increasing because of rising income levels, growing knowledge of genetic disorders and improved reproductive technology. There are several fertility clinics in India which have begun to provide PGD services and use preimplantation genetic testing for aneuploidy (PGT-A) amongst other methods to increase the rates of IVF procedures. The Indian government is in fact making efforts to promote ethical utilization of genetic testing in the country. But culture and education level could play a part in PGD service accessibility. The market is expected to flourish with more couples planning for implantation of healthy embryos in their womb.
• Japan: JapanÄX%$%Xs PGD market is expanding with modern technologies and a point of view devoted to biomedical ethics. The country has also recorded high funding for genetic testing studies, especially NGS facilitating a wider scope of embryo evaluation. Anyhow, legal restrictions related to genetically modified crops as well as ethical restrictions present boundaries for the conducive application of PGD services. Demand for PGD services in Japan is gradually increasing following the government’s campaign against genetic disorders. Joint efforts by healthcare providers on the one hand and researchers on the other are enabling the further enhancement of genetic screening strategies which is beneficial for the development of market.
Emerging Trends in the Preimplantation Genetics Diagnosis Market
The PGD market is undergoing several transformations due to the development of few once unfathomable trends which are likely to comprise of the efficiency level of genetic screening.
• Current Standards in Pre-implantation Genetic Diagnosis: Work on NGS technology has been introduced within PGD, allowing investigators to perform deeper genetic analysis on embryos. This allows for precise evaluation of genetic defects which will lead to better outcomes of IVF treatment and reduction of genetic diseases.
• Telemedicine Inclusion: Telemedicine incorporation into PGD service provision is also improving the convenience of these genetic screening procedures for the couples. Remote consultations enable the patient to have access to specialist advice and direction on site without any geographical limitations and therefore promote PGD.
• Progression Towards Wil be Personalized: There are also apparent changes in the PGD market in response to the growing demand for predictive medicine for genetic screening processes in particular. This change allows for more effective and efficient management of couples facing the prospect of advanced reproductive therapies.
• Other Networks were Established: This is due to the fact that genetic testing continues to be acknowledged by government and regulatory authorities, there is also a movement promoting the development of clear procedures and policies on particular areas. Such advances are directed towards the improvement of the safety, efficiency, and proper usage of PGD.
• Public Awareness Campaigns: The health campaigns on genetic disorders have increased the need for PGD. Campaigns geared towards increasing the public hysteria about the advantages of genetic screening have led couples to incorporate PGD in their family planning.
These trends are all together transforming the PGD market through provision of improved technology, improved access to patients and a more educated society, and thus improving the overall reproductive health.
Recent Developments in the Preimplantation Genetics Diagnosis Market
There are certain developmental trends which are developing in a preimplantation genetics diagnosis market to improve the diagnostic capabilities and patients return.
• Advancements in Genetic Testing Technology: With the integration of more advanced PGD techniques such as NGS and CRISPR, the art of PGD has taken a different direction. These technologies provide capabilities of carrying out more forensic investigations of embryos with a view to increasing the success of pregnant among treated woman.
• Expansion of IVF Clinics Offering PGD: More and more of fertility clinics across the globe have now made availability of PGD for it’s clients. This growth has happened due to the increase in the demand of genetic testing for patients, and the wish of better reproductive results making PGD more available to the couples wanting children.
• Governance and Legalizations: With increasing acceptance of PGD in the society, it is important to work on the ethical and regulatory governance frameworks. Countries are coming up with policies aimed at the mitigation of risks associated with the genetic diagnosis, modification and use.
• Relationships and Alliances: Those developments in PGD have been driven by the active collaboration of research centers, fertility centers and biotechnology corporations. The objective of these partnerships is to create new technologies and enhance the existing ones by optimizing the processes of genetic tests.
• Focus on Genetic Counseling Services: There is an increasing focus on PGD in association with the provision of genetic counseling services. This trend ensures that quality information and support about all the available options is provided to couples and hence enables them to make appropriate decisions regarding their reproductive health.
These trends have been changing the PGD market by increasing the technology, increasing the reach and also availability of ethical practices promoting better results for couples seeking genetic screening.
Strategic Growth Opportunities for Preimplantation Genetics Diagnosis Market
PGD market has identified various potential opportunities for strategic development with respect to several important applications that will help in delivering enhanced patient care along with improved diagnostic capability.
• Home-Based Genetic Testing Kits: The availability of genetic testing kits designed for home use can be said to provide a great potential for future expansion. They allow individuals who seek access to PGD consultations to perform basic tests at home and discuss the outcomes with practitioners.
• Innovative Genetic Counseling Services: It seems to be beneficial to patients to provide more genetic counseling than PGD only during the ART process. Patients are satisfied with the clinics, as they offer all forms of counseling, and their results are favorable.
• Expansion into Emerging Markets: This desire creates a gap in the market that PGD service providers are able to fill as they enter emerging markets which have bettering healthcare systems. Seeing the growing concern of genetic disorders, the chances are that the demand for PGD will also be high in these regions.
• Technological Collaborations: There is a need for new developments in the field of PGD, which will require cooperation with organizations engaged in genetic testing. These collaborative activities provide the way to implement the new generation of diagnostic methods the introduction of which is recommended for improvement of genetic screening efficiency.
• Public-Private Partnerships for Awareness Campaigns: The involvement in public-private partnerships for the promotion of genetic disorders and PGD is likely to be beneficial in expanding the market. These campaigns would help enlighten the general population and alleviate discrimination, leading to more couples opting for genetic tests.
Such opportunities in this space are transforming the PGD industry by enriching access, engendering innovations, and enabling patients’ decision-making which consequently leads to enhanced reproductive health.
Preimplantation Genetics Diagnosis Market Driver and Challenges
The PGD market is dynamic and runs on various drivers and challenges that define growth progression in the market. For stakeholders in this changing playing field, it is imperative for them to know these factors.
The factors responsible for driving the preimplantation genetics diagnosis market include:
1. Growing burden of genetic diseases: The rising prevalence of genetic disorders, including chromosomal blunders, is an increasing opportunity for the PGD market. As logic about the risks of genetic diseases increases, a more considerable number of couples are therefore going for the genetic tests.
2. Technological Advancements: Emerging genetic tests technologies e.g. NGS and CRISPR are improving the precision and performance of PGD. Such improvements are leading to better performance of reproductive health endeavors.
3. Growing Acceptance of Assisted Reproductive Technologies (ART): There is a growing awareness towards the ART therapies, PGD included, is enhancing growth in the market. With better perception on fertility treatment, more people are looking for routes for genetic tests that could be beneficial to them.
4. Increasing emphasis on Targeted therapies: The conversion of health care into a prospective, predictive and personalized ‘medicine’ adds momentum for developing focused molecular screening tools. Such an intervention enhances positive results of patients since there is optimal targeting as per the individual genetic make-up.
5. Government Initiatives and Regulations: Such supportive government measures and legal systems which are encouraging genetic testing are positioning the PGD market positively. These measures have an objective of ensuring ethical conduct and enhancement of utilization of genetic services.
Challenges in the preimplantation genetics diagnosis market are:
1. Ethical Concerns and Stigmas: Most couples may shy away from opting for genetic tests and PGD mainly due to ethical issues connected with it and possible negative perceptions. It is necessary to deal with these matters if one hopes to increase the acceptability and the use of this therapy.
2. Cost of Genetic Testing Services: The price of PGD and related procedures is very high and this denies some patients the opportunity to access such services especially in the low-income areas. Identifying means of lowering the costs in delivering such services is very important for the growth of the market.
3. Regulatory Barriers: In a bid to provide PGD services, confusion from different PCG rules may serve as a hindrance for supplies. In situations where there are regulations this regulation and such variations that exist region to region may inhibit the growth and advancement in the market.
The PGD market is characterized by both factors which propel growth as well as factors which are rendering navigation critical in the overall development thanks to the growth of the prevalence of genetic abnormalities, and inflicting competence on technological prospects. At the same time, it emerges that taking care of ethical considerations as well as improving access will be key to optimization of the potential of the market.
List of Preimplantation Genetics Diagnosis Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies preimplantation genetics diagnosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the preimplantation genetics diagnosis companies profiled in this report include-
• Perkinelmer Agilent Technologies
• Cegat
• Laboratory Corporation Of America Holdings
• Illumina
• Invitae Corporation
• Pacgenomics
• Quest Diagnostics
• Natera
• Reproductive Genetic Innovations (Rgi)
Preimplantation Genetics Diagnosis by Segment
The study includes a forecast for the global preimplantation genetics diagnosis by type, end use, and region.
Preimplantation Genetics Diagnosis Market by Type [Analysis by Value from 2018 to 2030]:
• Chromosomal Abnormalities
• Aneuploidy
• X-linked diseases
• Single Gene Disorders
• HLA Typing
• Gender selection
• Others
Preimplantation Genetics Diagnosis Market by End Use [Analysis by Value from 2018 to 2030]:
• Diagnostic Laboratories
• Hospitals
• Clinics
• Others
Preimplantation Genetics Diagnosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Preimplantation Genetics Diagnosis Market Insights
Lucintel forecasts that aneuploidy is expected to witness highest growth over the forecast period due to the growing adoption of aneuploidy screening methods and the introduction of novel products into the market.
Hospitals will remain the largest segment due to increasing admissions of patients, improvement in healthcare infrastructure, and availability of public as well as private hospitals in the region.
APAC is expected to witness highest growth over the forecast period due to increasing adoption of IVF translates and growing awareness levels among people in the region.
Features of the Global Preimplantation Genetics Diagnosis Market
Market Size Estimates: Preimplantation genetics diagnosis market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Preimplantation genetics diagnosis market size by type, end use, and region in terms of value ($B).
Regional Analysis: Preimplantation genetics diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the preimplantation genetics diagnosis market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the preimplantation genetics diagnosis market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
FAQ
Q.1 What is the preimplantation genetics diagnosis market size?
Answer: The global preimplantation genetics diagnosis market is expected to reach an estimated $0.20 billion by 2030.
Q.2 What is the growth forecast for preimplantation genetics diagnosis market?
Answer: The global preimplantation genetics diagnosis market is expected to grow with a CAGR of 10.7% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the preimplantation genetics diagnosis market?
Answer: The major drivers for this market are rising prevalence of genetic disorder, growing awareness about the role of genetics in reproductive health, and technological advancement in the fertility treatments.
Q4. What are the major segments for preimplantation genetics diagnosis market?
Answer: The future of the preimplantation genetics diagnosis market looks promising with opportunities in the diagnostic laboratory, hospital, and clinic markets.
Q5. Who are the key Preimplantation Genetics Diagnosis Market companies?
Answer: Some of the key preimplantation genetics diagnosis companies are as follows:
• PerkinElmer Agilent Technologies
• Cegat
• Laboratory Corporation of America Holdings
• Illumina
• Invitae Corporation
• Pacgenomics
• Quest Diagnostics
• Natera
• Reproductive Genetic Innovations (RGI)
Q6. Which preimplantation genetics diagnosis market segment will be the largest in future?
Answer: Lucintel forecasts that aneuploidy is expected to witness highest growth over the forecast period due to the growing adoption of aneuploidy screening methods and the introduction of novel products into the market.
Q7. In preimplantation genetics diagnosis market, which region is expected to be the largest in next 6 years?
Answer: APAC is expected to witness highest growth over the forecast period due to increasing adoption of IVF translates and growing awareness levels among people in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the preimplantation genetics diagnosis market by type (chromosomal abnormalities, aneuploidy, X-linked diseases, single gene disorders, HLA typing, gender selection, and others), end use (diagnostic laboratories, hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Preimplantation Genetics Diagnosis Market, Preimplantation Genetics Diagnosis Market Size, Preimplantation Genetics Diagnosis Market Growth, Preimplantation Genetics Diagnosis Market Analysis, Preimplantation Genetics Diagnosis Market Report, Preimplantation Genetics Diagnosis Market Share, Preimplantation Genetics Diagnosis Market Trends, Preimplantation Genetics Diagnosis Market Forecast, Preimplantation Genetics Diagnosis Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.